Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2021-12-01 00:00:00 ET · period of report 2021-11-29 · accession 0001209191-21-067380 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-12-01 | 2021-11-29 | VIR | HANLY ANN M. | CTO | P - Purchase | $43.39 | +11.52 | 11.52 | New | +$499.85 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-29 | P | A | 11.52 | $43.39 | 11.52 | I See footnote | — | — | (F1) The purchase was effectuated by a minor through a trading account registered in the name of the reporting person's spouse. |